The introduction of new vaccines into developing countries: IV: Global Access Strategies
- 16 May 2007
- journal article
- review article
- Published by Elsevier BV in Vaccine
- Vol. 25 (20), 4003-4011
- https://doi.org/10.1016/j.vaccine.2007.02.047
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Health Innovation Networks to Help Developing Countries Address Neglected DiseasesScience, 2005
- Vaccines for otitis media: proposals for overcoming obstacles to progressVaccine, 2005
- Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trialThe Lancet, 2005
- Public-Private Partnership in the Development of the Hepatitis B Vaccine in Korea: Implications for Developing CountriesScience, Technology and Society, 2005
- Virtual drug discovery and development for neglected diseases through public–private partnershipsNature Reviews Drug Discovery, 2003
- “Market-stimulating” technology policies in developing countries: A framework with examples from East AsiaWorld Development, 1998
- Technological capabilities and industrializationWorld Development, 1992
- Cost of plasma-derived hepatitis B vaccine productionVaccine, 1990
- Technology development processes: A model for a developing country with a global perspectiveR&D Management, 1988
- Developing countries as exporters of industrial technologyResearch Policy, 1980